Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with st segment elevated acute myocardial infarction undergoing primary angioplasty

Cardiology

Volumn 105, Issue 3, 2006, Pages 168-175

  Uyarel, Huseyin ^a,b   Uzunlar, Bulent ^a   Dayi, Sennur Unal ^a   Tartan, Zeynep ^a   Samur, Hasan ^a   Kasikcioglu, Hulya ^a   Akgul, Ozgur ^a   Simsek, Dilek ^a   Erdem, Ismail ^a   Okmen, Ertan ^a   Cam, Nese ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Glycoprotein IIb IIIa; Primary angioplasty; ST segment resolution; Thrombolyis in myocardial infarction III flow

Indexed keywords

FIBRINOGEN RECEPTOR; TIROFIBAN;

ACUTE HEART INFARCTION; ADULT; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CARDIAC PATIENT; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION INJURY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; ST SEGMENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEART CONDUCTION SYSTEM; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; STENTS; STROKE VOLUME; TREATMENT OUTCOME; TYROSINE;

EID: 33645471920     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091403     Document Type: Article

References (35)

1. Kloner RA, Ganote CE, Jennings RB: The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54: 1496-1508.
2. Ito H, Okamura A, Iwakura K, et al: Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996;93:1993-1999.
3. van't Hof AWJ, Liem A, de Boer MJ, et al: Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997;350:615-619.
4. Muller JE, Maroko PR, Braunwald E: Precordial electrocardiographic mapping: a technique to assess the efficacy of interventions designed to limit infarct size. Circulation 1978; 57:1-18.
5. Kenner MD, Zajac EJ, Kondos GT, et al: Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995;76:861-868.
6. Santoro M, Valenti R, Buonamici P, et al: Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 1998;82:932-937.
7. de Lemos JA, Braunwald E: ST-segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001;38: 1283-1294.
8. Gibson CM: Time is myocardium and time is outcomes. Circulation 2001;104:2632-2634.
9. Anderson KM, Califf RM, Stone GW, et al: Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2001;37:2059-2065.
10. Neumann FJ, Blasini R, Schmitt C, et al: Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction. Circulation 1998;98:2695-2701.
11. Boersma E, Harrington RA, Moliterno DJ, et al: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomized clinical trials. Lancet 2002;359:189-198.
12. Kochman W, Dobrzycki S, Nowak KS, et al: Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study. J Thromb Thrombolysis 2004;17:127-131.
13. Yeh KH, Chen MC, Chang HW, et al: Effect of adjunctive tirofiban therapy on angiographic and clinical outcomes in patients with ST-segment elevated acute myocardial infarction undergoing primary stenting. Jpn Heart J 2004;45:31-41.
14. Nakagawa Y, Ito H, Kitakaze M, et al: Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: new insights using myocardial contrast echocardiography. Circulation 1994; 89:2562-2569.
15. Iwakura K, Ito H, Kawano S, et al: Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001;38:472-477.
16. Schröder R: Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004;110:506-510.
17. Ellis SG, Vandormael MG, Cowley MJ, et al: Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection: Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82: 1193-1202.
18. Chesebro JH, Knatterud G, Roberts R, et al: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-154.
19. Rentrop KP, Cohen M, Blanke H, et al: Change in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-592.
20. Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2: 358-367.
21. Killip T, Kimball JT: Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457-464.
22. de Lemos JA, Antman EM, Giugliano RP, et al: ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy: Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. Am J Cardiol 2000;85:299-304.
23. Dong J, Ndrepepa G, Schmitt C, et al: Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation 2002;105:2946-2949.
24. Schroder R, Wegscheider K, Schroder K, et al: Extent of early ST-segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens: a substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 1995;26:1657-1664.
25. Zhao XQ, Theroux P, Snapinn SM, et al: Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS trial (platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). Circulation 1999;100:1609-1615.
26. de Lemos JA, Antman EM, Gibson CM, et al: Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: observations from the TIMI 14 trial. Circulation 2000;101:239-243.
27. Brener SJ, Barr LA, Burchenal JE, et al: Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation 1998;98:734-741.
28. Gibson CM, Cohen DJ, Cohen EA, et al: Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Am J Cardiol 2001;87:1293-1295.
29. Manciet LH, Poole DC, McDonagh PF, et al: Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon. Am J Physiol 1994;266:H1541-H1550.
30. Mukherjee D, Moliterno DJ: Achieving tissue-level perfusion in the setting of acute myocardial infarction. Am J Cardiol 2000;85:39C-46C.
31. Saitoh S, Onogi F, Aikawa K, et al: Multiple endothelial injury in epicardial coronary artery induces downstream microvascular spasm as well as remodeling partly via thromboxane A2. J Am Coll Cardiol 2001;37:308-315.
32. Shen YT, Wiedmann RT, Lynch JJ, et al: Platelet glycoprotein IIb/IIIa receptor inhibitor preserves coronary flow reserve during progressive coronary arteriostenosis in swine. Arterioscler Thromb Vasc Biol 2000;20:2309-2315.
33. Hellstrom HR: The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic disease: resistance vessel-spasm hypothesis of ischemic disease. Am J Cardiol 1982;49:802-810.
34. Kunichika H, Ben-Yehuda O, Lafitte S, Kunichika N, Peters B, DeMaria AN: Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. J Am Coll Cardiol 2004;43:276-283.
35. Jordan RE, Wagner CL, Mascelli M, et al: Pre-clinical development of c7E3 Fab: mouse/human chimeric monoclonal antibody fragment that inhibits platelet function by blockade of GP IIb/IIIa receptors with observations on the immunogenicity of c7E3 Fab in humans; in Horton MA (ed): Adhesion Receptors as Therapeutic Targets. Boca Raton, CRC Press, 1996, pp 281-305.